The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons
Open accessAbstract
Animal and epidemiological studies suggest that polyphenol constituents of red wine possess antioxidant activities that favour protection against cardiovascular disease – the so‐called. ‘French paradox’ – and possibly, central nervous system disorders such as Alzheimer's disease (AD) and ischaemia. In the present study, the potential of three major red wine derived‐polyphenols to protect against toxicity induced by the nitric oxide free radical donors sodium nitroprusside (SNP) and 3‐morpholinosydnonimine (SIN‐1) was examined in cultured rat hippocampal cells. Both co‐ and post‐treatments with either the stilbene resveratrol (5–25 μ M) or the flavonoids quercetin (5–25 μ M) and (+)‐catechin (1–10 μ M) were capable of attenuating hippocampal cell death and intracellular reactive oxygen species accumulation produced by SNP (100 μ M and 1 m M, respectively). However, among the phenolic compounds tested, only the flavonoids afforded significant protection against 5 m M SIN‐1‐induced toxicity. The effects of phenolic constituents were shared by Trolox (100 μ M), a vitamin E analogue, but not by selective inhibitors of cyclo‐oxygenases (COX) and lipoxygenases (LOX). Among the phenolic compounds tested, only quercetin (10 μ M) inhibited 100 μ M SNP‐stimulated protein kinase C (PKC) activation, whereas none of them were able to attenuate nitrite accumulation caused by SNP (100 μ M). Taken together, these data suggest that the neuroprotective abilities of quercetin, resveratrol, and (+)‐catechin result from their antioxidant properties rather than their purported inhibitory effects on intracellular enzymes such as COX, LOX, or nitric oxide synthase. Quercetin, however, may also act via PKC to produce its protective effects. British Journal of Pharmacology (2000) 131, 711–720; doi:10.1038/sj.bjp.0703626
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Review of the biology of quercetin and related bioflavonoids
Formica, J. V., & Regelson, W. (1995) · Food and Chemical Toxicology · doi:10.1016/0278-6915(95)00077-1 · Cited by 1,765
Flavonoids are scavengers of superoxide anions
Robak, J., & Gryglewski, R. J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90169-4 · Cited by 1,575
Nitric oxide activates cyclooxygenase enzymes.
Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., & Needleman, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7240 · Cited by 1,395
Mechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction
Liu, Y., Peterson, D. A., Kimura, H., & Schubert, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020581.x · Cited by 1,034
Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices
Hertog, M. G. L., Hollman, P. C. H., & van de Putte, B. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00032a015 · Cited by 895
Selective vulnerability of the hippocampus in brain ischemia
Schmidt-Kastner, R., & Freund, T. F. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90001-5 · Cited by 888
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G., & Goldberg, D. M. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06045-1 · Cited by 874
Resveratrol: A molecule whose time has come? And gone?
Soleas, G. J., Diamandis, E. P., & Goldberg, D. M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00155-5 · Cited by 849
Cited by
Phenolics as potential antioxidant therapeutic agents: Mechanism and actions
Soobrattee, M. A., Neergheen, V. S., Luximon-Ramma, A., Aruoma, O. I., & Bahorun, T. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.03.023 · Cited by 1,504
Porat, Y., Abramowitz, A., & Gazit, E. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2005.00318.x · Cited by 989
Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681
Papuc, C., Goran, G. V., Predescu, C. N., Nicorescu, V., & Stefan, G. (2017) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12298 · Cited by 561
Biological Effects of Resveratrol
Bhat, K. P. L., Kosmeder, J. W., & Pezzuto, J. M. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601317203567 · Cited by 507
Singh, M., Arseneault, M., Sanderson, T., Murthy, V., & Ramassamy, C. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0735073 · Cited by 439
Vauzour, D. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/914273 · Cited by 424
Neuroprotective action of resveratrol
Bastianetto, S., Ménard, C., & Quirion, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.011 · Cited by 407
Self-citationNutritional approaches to combat oxidative stress in Alzheimer’s disease
Butterfield, D. A., Castegna, A., Pocernich, C. B., Drake, J., Scapagnini, G., & Calabrese, V. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00205-x · Cited by 403
Levites, Y., Amit, T., Mandel, S., & Youdim, M. B. H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0881fje · Cited by 373
Review on Alzheimer’s Disease: Inhibition of Amyloid Beta and Tau Tangle Formation
Ashrafian, H., Zadeh, E. H., & Khan, R. H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.192 · Cited by 368
Kainic Acid-Mediated Excitotoxicity as a Model for Neurodegeneration
Wang, Q., Yu, S., Simonyi, A., Sun, G. Y., & Sun, A. Y. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:003 · Cited by 362
Hormetic Dietary Phytochemicals
Son, T. G., Camandola, S., & Mattson, M. P. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8037-y · Cited by 356
Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses
Mattson, M. P., & Cheng, A. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.001 · Cited by 355
Sinha, K., Chaudhary, G., & Kumar Gupta, Y. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01691-0 · Cited by 354
MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide
SCHROETER, H., BOYD, C., SPENCER, J., WILLIAMS, R., CADENAS, E., & RICEEVANS, C. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00075-1 · Cited by 340
Resveratrol—A boon for treating Alzheimer's disease?
Anekonda, T. S. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.04.004 · Cited by 339
Ono, K., & Yamada, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03707.x · Cited by 320
Neuroinflammation: Modulation by flavonoids and mechanisms of action
Spencer, J. P. E., Vafeiadou, K., Williams, R. J., & Vauzour, D. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.016 · Cited by 315
“This potential may reside in a number of physiological functions, including their antioxidant properties (Bastianetto et al., 2000), their interactions with intracellular signaling pathways, the regulation of cell survival/apoptotic genes and mitochondrial function (Spencer, 2009b; Spencer et al.,…”
BackgroundChoi, D.-Y., Lee, Y.-J., Hong, J. T., & Lee, H.-J. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.014 · Cited by 305
Han, Y., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 297
Self-citationMetabolism and pharmacokinetics of resveratrol and pterostilbene
Wang, P., & Sang, S. (2018) · BioFactors · doi:10.1002/biof.1410 · Cited by 289
Bastianetto, S., Yao, Z., Papadopoulos, V., & Quirion, R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04532.x · Cited by 282
Self-citationNeuroprotective effect of natural products against Alzheimer’s disease
Essa, M. M., Vijayan, R. K., Castellano-Gonzalez, G., Memon, M. A., Braidy, N., & Guillemin, G. J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0799-9 · Cited by 278
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
Calabrese, E. J., Mattson, M. P., & Calabrese, V. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110383625 · Cited by 273
Resveratrol: Preventing properties against vascular alterations and ageing
Delmas, D., Jannin, B., & Latruffe, N. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200400098 · Cited by 269
Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, T. E., Giuffrida Stella, A. M., Schapira, T., Dinkova Kostova, A. T., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9775-9 · Cited by 268
Aquilano, K., Baldelli, S., Rotilio, G., & Ciriolo, M. R. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9697-6 · Cited by 265
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.008 · Cited by 265
Mitochondria in cell death: novel targets for neuroprotection and cardioprotection
Mattson, M. P., & Kroemer, G. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00046-7 · Cited by 264
Candelario-Jalil, E., de Oliveira, A. C. P., Gräf, S., Bhatia, H. S., Hüll, M., Muñoz, E., & Fiebich, B. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-25 · Cited by 223
“One of the most interesting properties of resveratrol is its ability to confer potent neuroprotection in several models of brain injury, both in vitro [10-12] and in vivo [7,8,13,14].”
Griñán-Ferré, C., Bellver-Sanchis, A., Izquierdo, V., Corpas, R., Roig-Soriano, J., Chillón, M., Andres-Lacueva, C., Somogyvári, M., Sőti, C., Sanfeliu, C., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101271 · Cited by 208
Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment
Andrade, S., Ramalho, M. J., Pereira, M. D. C., & Loureiro, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01261 · Cited by 173
Vauzour, D., Corona, G., & Spencer, J. P. E. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.03.016 · Cited by 166
Viewpoint: Mechanisms of Action and Therapeutic Potential of Neurohormetic Phytochemicals
Mattson, M. P., Son, T. G., & Camandola, S. (2007) · Dose-Response · doi:10.2203/dose-response.07-004.mattson · Cited by 137
“Resveratrol can protect cultured neurons against nitric oxide-mediated oxidative stress-induced death (Bastianetto et al., 2000).”
Metadata
- Authors
- Bastianetto, S., Zheng, W., & Quirion, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-10
- Volume
- 131
- Issue
- 4
- Pages
- 711-720
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2064305999
- Cited by
- 302
- References
- 55
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.